drugset / Trial / NCT04054687
Intranasal TXA for Anterior Epistaxis in the Emergency Department
RandomizedSingle-groupSingle-blindTreatment
Summary
The objective of this study is to evaluate the efficacy of and patient satisfaction with the use of intranasal tranexamic acid (TXA) for anterior nosebleeds in the emergency department (ED).
Timeline
- Start
- 2019-11-07
- Primary completion
- 2021-04
- Completion
- 2021-05
Outcome
Outcome not reported
Stopped: “Due to coronavirus pandemic”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 100 mg | Other |
Indications
No indication recorded.